RxDoctor Payments Data

Benjamin Baird

Surgical · Roseburg, ORNPI 1417252990

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $4,926 of the $6,002 with a category attached, or 82.1%. Medacta USA, Inc. accounts for 72.8% of it on its own, with 6 other manufacturers making up the rest. 2025 is the largest year on record at $3,164, 2.2 times the $1,458 reported in 2022. Among surgical clinicians in OR with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$6,002in general payments, 2019–2025

Across 35 payments — averaging $171.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medacta USA, Inc.$4K
  • Pacira Pharmaceuticals Incorporated$2K
  • DJO, LLC$28
  • Smith+Nephew$23
  • Sanara Medtech Inc.$20
  • E.r. Squibb & Sons, L.L.C.$15
  • plus $15 from 1 others

What the payments were for

  • Travel & lodging$4,92682%
  • Food & beverage$1,07618%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,002 in reported general payments places this provider in the 95th percentile of 229 surgical providers in Oregon.

See all surgical providers in Oregon

Medicare billing

Part B allowed, 2024
$117,332
Medicare patients
306
Services billed
2,315

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban19$6,233
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen367$2,978
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen54$475
Celecoxib13$350
Meloxicam59$341
Ondansetron OdtOndansetron16$160
Tramadol Hcl48$150
Gabapentin17$86
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim17$40
Amoxicillin12$38

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$15$6,23319 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 229 surgical providers in Oregon.

Other surgical in Roseburg

See the full list for Oregon

Where these figures come from

Is this you, or does something look wrong? →